6th Nov 2018 16:29
LONDON (Alliance News) - Faron Pharmaceuticals Oy on Tuesday said VP Drug Development Chief Medical Officer Matti Karvonen acquired shares in the biopharmaceutical company.
In a transaction on October 26, Karvonen bought 20,000 shares at a price of 82.90 pence per share, worth GBP16,580.
Shares in Faron Pharmaceuticals were trading 0.7% higher on Tuesday at 76.50p each.
Related Shares:
Faron Pharmaceuticals